Pascoe Pharmazeutische Praeparate GmbH   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Giessen Germany (1895)
Status: No NME R&D (1895)

Organization Overview

First Clinical Trial
2001
NCT00997490
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pascoe Pharmazeutische Praeparate GmbH

Active Ingredients

Drugs in Phase 4 Trials (1)

passion flower (3 trials)

Drugs in Phase 3 Trials (1)

neurapas (3 trials)

Drugs in Phase 2 Trials (2)

devil claw (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depressive Disorder (Phase 3)

Osteoarthritis (Phase 2)

Osteoarthritis, Hip (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 4